title: In vivo safety evaluation of polyarginine coated magnetic nanovectors.
abstract: Safety and efficacy are of critical importance to any nanomaterial-based diagnostic and therapy. The innocuity and functionality of a nanomaterial in vivo is largely dependent on the physicochemical properties of the material, particularly its surface coating. Here, we evaluated the influence of polycationic coating on the efficacy, clearance organ uptake, and safety of magnetic nanovectors designed for siRNA delivery. Polyethylene glycol (PEG) coated superparamagnetic iron oxide nanoparticles (NPs) of 12 nm in core diameter were modified with a polycationic coating of either poly-l-arginine (pArg) or polyethylenimine (PEI) and further covalently functionalized with siRNA oligonucleotides. The produced NP-pArg-siRNA and NP-PEI-siRNA nanovectors were similar in hydrodynamic size (21 and 22 nm, respectively) but significantly differed in zeta potentials (+2.1 mV and +29.8 mV, respectively). Fluorescence quantification assays revealed that the NP-pArg-siRNA nanovector was 3-fold more potent than NP-PEI-siRNA in delivering siRNA and 1.8-fold more effective in gene silencing when tested in rat C6 glioblastoma cells. In vivo, both nanovector formulations were similarly taken up by the spleen and liver as determined by histopathological and hemopathological assays. However, PEI coated nanovectors elicited severe hemoincompatibility and damage to the liver and spleen, while pArg coated nanovectors were found to be safe and tolerable. Combined, our findings suggest that polycationic coatings of pArg were more effective and safer than commonly used PEI coatings for preparation of nanovectors. The NP-pArg-siRNA nanovector formulation developed here shows great potential for in vivo based biomedical applications.
authors.affiliation: Department of Materials Science and Engineering, University of Washington , Seattle, Washington 98195, United States.
authors.forename: Omid
authors.initials: O
authors.lastname: Veiseh
authors.forename: Forrest M
authors.initials: FM
authors.lastname: Kievit
authors.forename: Vicki
authors.initials: V
authors.lastname: Liu
authors.forename: Chen
authors.initials: C
authors.lastname: Fang
authors.forename: Zachary R
authors.initials: ZR
authors.lastname: Stephen
authors.forename: Richard G
authors.initials: RG
authors.lastname: Ellenbogen
authors.forename: Miqin
authors.initials: M
authors.lastname: Zhang
mesh_terms: D005290:Ferric Compounds / Q000737:chemistry; D015316:Genetic Therapy; D053758:Nanoparticles / Q000737:chemistry; D036103:Nanotechnology / Q000379:methods*; D010455:Peptides / Q000737:chemistry*; D011092:Polyethylene Glycols / Q000737:chemistry; D011094:Polyethyleneimine / Q000737:chemistry; D034741:RNA, Small Interfering
chemical_list: D005290:Ferric Compounds; D010455:Peptides; D034741:RNA, Small Interfering; C000499:ferric oxide; C015462:polyarginine; D011092:Polyethylene Glycols; D011094:Polyethyleneimine